Presented by the Johns Hopkins University School of Medicine
In collaboration with DKBmed, LLC
Supported by an independent educational grant from Gilead Sciences, Inc.

Part 1: SAVA Origins and Epidemiology

Dr. Anderson discusses the prevalence and incidence of SAVA, addressing the cycle of substance abuse, violence, and declining patient outcomes. Clinicians will learn about the SAVA syndemic and how substance abuse, violence, and depression can detrimentally affect patients’ outcomes.

Post-Test

Part 2: Addressing SAVA: Screening and Treatment

In part two, Dr. Anderson addresses available screeners, with specific emphasis on those used at the HIV Women’s Clinic. She gives an overview of each of the screening tools and discusses with clinicians how best to initiate the conversation. A system to link patients to support networks is established, and Dr. Anderson expresses the importance of prompt, sensitive screening.

Post-Test

Presented by the Johns Hopkins University School of Medicine
In collaboration with DKBmed, LLC

Supported by an independent educational grant from Gilead Sciences, Inc.

Women with HIV are at significant risk for interpersonal violence and substance abuse.

The SAVA syndemic (substance abuse, violence, and HIV/AIDs) imposes additional burden on an already vulnerable population. Women afflicted with SAVA have significantly lower adherence to their HIV medication and reduced viral suppression.

But they’re being missed by their HIV clinicians, for one simple reason: they do not know.

You are on the frontlines. Now is the time for you to take action against SAVA.

You can help. Tune in to ODM: Finding the Invisible Patient with Jean Anderson, MD. Learn how to:

  • Recognize the impact SAVA has on patient adherence and quality of life.
  • Regularly screen patients for interpersonal violence and substance abuse.
  • Refer patients to appropriate care (social service, psychiatric and substance abuse specialists) when they screen positive for elements of SAVA.

Presented by the Johns Hopkins University School of Medicine
In collaboration with DKBmed, LLC
Supported by an independent educational grant from Gilead Sciences, Inc.

Program Director

Jean R. Anderson, MD
Professor of Gynecology and Obstetrics
Director, Division of Gynecologic Specialties
Director, Johns Hopkins HIV Women’s Health Program/Gynecology and Obstetrics
Johns Hopkins University School of Medicine
Baltimore, Maryland


Faculty

Joyce Leitch Jones, MD, MS
Clinical Associate
Johns Hopkins University School of Medicine
Director, South Carolina Clinical and Translational Research Institute
Baltimore, Maryland

Alison Livingston, RN
Program Nurse Manager-Outreach supervisor
Johns Hopkins University School of Medicine
The Johns Hopkins HIV Women's Health Program
Baltimore, Maryland


Presented by the Johns Hopkins University School of Medicine
In collaboration with DKBmed, LLC
Supported by an independent educational grant from Gilead Sciences, Inc.

CME/CE

Accreditation Statement

The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.


Credit Designation Statement

The Johns Hopkins University School of Medicine designates this enduring material – internet activity – for a maximum of 1.0 AMA PRA Category 1 Credit. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Course Format

Optimizing Disease Management: Finding the Invisible Patient is a pre-recorded live lecture presented at the Bartlett Specialty Clinic for specialist clinicians currently practicing at the Bartlett Specialty Clinic and the HIV Women’s Clinic. Participants will have up to 2 years to complete the enduring webcast in order to earn CME credit.

Date of release: 3/1/2019
Expiration date: 6/1/2021

Estimated time to complete each activity: 0.5 hours (1.0 hours total).

Target Audience

This activity has been designed to meet the educational needs of internal medicine/family practice clinicians.

Learning Objectives

After participating in this activity, the participant will demonstrate the ability to:

  • Recognize the impact substance abuse, interpersonal violence, and HIV/AIDS (SAVA) and depression have on patient adherence and quality of life.
  • Regularly screen patients for interpersonal violence and substance abuse.
  • Refer patients to appropriate care when screening tests appear positive for SAVA (social service, psychiatric and substance abuse specialists).

Statement of Responsibility

The Johns Hopkins University School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity.

Statement of Need

  • Clinicians do not recognize the prevalence of SAVA and its impact on patient adherence and outcomes.
  • Most clinicians do not screen for SAVA or address the cause of SAVA, which perpetuates the syndemic and leads to poorer adherence and patient outcomes.

Supported by an educational grant from Gilead Sciences, Inc.

Successful Completion

To receive credit, participants must (1) read the learning objectives and disclosure statements, (2) complete the educational activity, and (3) complete the post-test and activity evaluation form, including the certificate information section. Physicians must attest to the amount of time they spent on the activity.

A passing grade of 70% or higher on the post-test/evaluation is required to receive CME credit.

There are no fees or prerequisites for this activity.

Policy on Presenter and Provider Disclosure. It is the policy of the Johns Hopkins University School of Medicine that the presenter and provider globally disclose conflicts of interest. The Johns Hopkins University School of Medicine OCME has established policies that will identify and resolve conflicts of interest prior to this educational activity. Detailed disclosure will be made prior to presentation of the education.

Full Disclosure Policy Affecting CME Activities

As a provider approved by the Accreditation Council for Continuing Medical Education (ACCME), Johns Hopkins University School of Medicine Office of Continuing Medical Education (OCME) requires attested and signed global disclosure of the existence of all financial interests or relationships with commercial interest from any individual in a position to control the content of a CME activity sponsored by OCME. The following relationships have been reported for this activity:

Jean R. Anderson, MD discloses that she is a stockholder for Gilead Sciences, Inc.

No one else in a position to control the content of this educational activity has disclosed a relevant financial interest or relationship with any commercial interest.

Note: Grants to investigators at The Johns Hopkins University are negotiated and administered by the institution which receives the grants, typically through the Office of Research Administration. Individual investigators who participate in the sponsored project(s) are not directly compensated by the sponsor, but may receive salary or other support from the institution to support their effort on the project(s).

Privacy Policy

The Office of Continuing Medical Education (CME) at the Johns Hopkins University School of Medicine is committed to protecting the privacy of its members and customers. Johns Hopkins University SOM CME maintains its Internet site as an information resource and service for physicians, other health professionals and the public. Continuing Medical Education at the Johns Hopkins University School of Medicine will keep your personal and credit information confidential when you participate in a CME Internet based program. Your information will never be given to anyone outside of the Johns Hopkins University School of Medicine's CME program. CME collects only the information necessary to provide you with the services that you request.

To participate in additional CME activities presented by the Johns Hopkins University School of Medicine Continuing Medical Education Office, please visit www.hopkinscme.cloud-cme.com

Disclaimer Statement

The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of the Johns Hopkins University School of Medicine name implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings, and adverse effects before administering pharmacologic therapy to patients.

Hardware & Software Requirements

PC: Internet Explorer (v9 or greater), Chrome or Firefox
MAC: Safari
Monitor settings: High color at 800 x 600 pixels, Sound card and speakers, Adobe Acrobat Reader.

Confidentiality Disclaimer for CME Activity Participants

I certify that I am participating in a Johns Hopkins University School of Medicine CME activity for accredited training and/or educational purposes.

I understand that while I am participating in this capacity, I may be exposed to "protected health information," as that term is defined and used in Hopkins policies and in the federal HIPAA privacy regulations (the Privacy Regulations). Protected health information is information about a person's health or treatment that identifies the person.

I pledge and agree to use and disclose any of this protected health information only for the training and/or educational purposes of my visit and to keep the information confidential. I agree not to post or discuss this protected health information, including pictures and/or videos on any social medial site (e.g. Facebook, Twitter, etc.), in any electronic messaging program or through any portable electronic device.

I understand that I may direct to the Johns Hopkins Privacy Officer any questions I have about my obligations under this Confidentiality Pledge or under any of the Hopkins policies and procedures and applicable laws and regulations related to confidentiality. The contact information is Johns Hopkins Privacy Officer, telephone: 410-735-6509, e-mail: HIPAA@jhmi.edu.

"The Office of Continuing Medical Education at the Johns Hopkins University School of Medicine, as provider of this activity, has relayed information with the CME attendees/participants and certifies that the visitor is attending for training, education and/or observation purposes only."

For CME questions, please contact the CME Office (410) 955-2959 or e-mail cmenet@jhmi.edu. For certificates, please call (410) 502-9636.

Johns Hopkins University School of Medicine Office of Continuing Medical Education Turner 20/720 Rutland AvenueBaltimore, Maryland 21205-2195

Reviewed & Approved by:
General Counsel, Johns Hopkins Medicine (4/1/03)
(Updated 4/09 and 3/14)

Copyright © 2018. JHUSOM and ODM: Finding the Invisible Patient
Presented by JHUSOM in collaboration with DKBmed